AMA: Payers must adopt more consistent coverage policies for genetic tests, therapeutics

FierceHealthcare – The American Medical Association wants payers to cover genetic tests and precision medicine more consistently, arguing their current practices may hinder patient access to cutting-edge tests and therapeutics.

Currently, there is significant variation between public and private payers when it comes to their evidentiary requirements for covering genetic tests and services, according to a report reviewed by physicians gathered at the trade group’s interim meeting in Honolulu, Hawaii. Plus, different insurers might review the same evidence yet reach conflicting conclusions about medical necessity and coverage of these services, the report noted.

Read more at FierceHealthcare.

News Image
AMA headquarters
Image Citation

PinotgrisCC BY-SA 3.0